Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis.

Li-Mei WangQi-Hua YangLei ZhangSheng-Yun LiuPan-Pan ZhangXin ZhangXiao-Jun LiuLi-Shuai HanTian-Fang Li

Published in: Rheumatology (Oxford, England) (2022)

IVIG adjunct therapy is a very effective first-line treatment for patients with MDA5-RPILD. IVIG may increase the survival and remission rate by lowering ferritin concentration, anti-MDA5 titre and GGO score.

Keyphrases

breast cancer cells
disease activity
interstitial lung disease
high dose
genome wide
rheumatoid arthritis
copy number
cell cycle arrest
systemic lupus erythematosus
stem cells
ulcerative colitis
free survival
systemic sclerosis
low dose
smoking cessation
replacement therapy